HealthEquity Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Los beneficios de HealthEquity han disminuido a una tasa media anual de -43.2%, mientras que en la industria Healthcare los beneficios crecieron en un 7.1% anualmente. Los ingresos han ido creciendo a una tasa media de 18.5% al año. La rentabilidad financiera de HealthEquity es de 2.7%, y sus márgenes netos son de 5.6%.
Información clave
-43.2%
Tasa de crecimiento de los beneficios
-49.5%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 8.5% |
| Tasa de crecimiento de los ingresos | 18.5% |
| Rentabilidad financiera | 2.7% |
| Margen neto | 5.6% |
| Última actualización de beneficios | 31 Jan 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Apr 12An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued
Mar 16HealthEquity: Quality Firm, But Not Likely Worth The Price
Mar 01These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Jan 28Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jan 02HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate
Dec 09Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Oct 10Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 36% Undervaluation?
Sep 05Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Aug 09Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero HealthEquity. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Jan 24 | 1,000 | 56 | 183 | 219 |
| 31 Oct 23 | 971 | 29 | 177 | 216 |
| 31 Jul 23 | 938 | 13 | 173 | 210 |
| 30 Apr 23 | 901 | -8 | 169 | 201 |
| 31 Jan 23 | 862 | -26 | 166 | 193 |
| 31 Oct 22 | 831 | -59 | 162 | 187 |
| 31 Jul 22 | 795 | -62 | 152 | 176 |
| 30 Apr 22 | 778 | -55 | 148 | 167 |
| 31 Jan 22 | 757 | -44 | 144 | 157 |
| 31 Oct 21 | 741 | -6 | 142 | 144 |
| 31 Jul 21 | 741 | 1 | 144 | 136 |
| 30 Apr 21 | 728 | 4 | 139 | 129 |
| 31 Jan 21 | 734 | 9 | 134 | 125 |
| 31 Oct 20 | 747 | 3 | 122 | 124 |
| 31 Jul 20 | 724 | -20 | 132 | 117 |
| 30 Apr 20 | 635 | 0 | 117 | 98 |
| 31 Jan 20 | 532 | 40 | 105 | 78 |
| 31 Oct 19 | 407 | 53 | 97 | 56 |
| 31 Jul 19 | 320 | 90 | 68 | 41 |
| 30 Apr 19 | 304 | 93 | 66 | 38 |
| 31 Jan 19 | 287 | 74 | 63 | 35 |
| 31 Oct 18 | 272 | 67 | 60 | 33 |
| 31 Jul 18 | 258 | 61 | 56 | 31 |
| 30 Apr 18 | 244 | 56 | 52 | 29 |
| 31 Jan 18 | 230 | 47 | 48 | 27 |
| 31 Oct 17 | 216 | 46 | 44 | 26 |
| 31 Jul 17 | 202 | 41 | 42 | 26 |
| 30 Apr 17 | 190 | 32 | 40 | 24 |
| 31 Jan 17 | 178 | 26 | 38 | 22 |
| 31 Oct 16 | 167 | 25 | 36 | 21 |
| 31 Jul 16 | 155 | 24 | 33 | 19 |
| 30 Apr 16 | 141 | 20 | 30 | 18 |
| 31 Jan 16 | 127 | 17 | 27 | 17 |
| 31 Oct 15 | 116 | 15 | 26 | 15 |
| 31 Jul 15 | 107 | 14 | 24 | 14 |
| 30 Apr 15 | 97 | 13 | 22 | 12 |
| 31 Jan 15 | 88 | 12 | 19 | 11 |
| 31 Oct 14 | 80 | 1 | 16 | 9 |
| 31 Jul 14 | 74 | -1 | 15 | 8 |
| 30 Apr 14 | 68 | -4 | 13 | 8 |
| 31 Jan 14 | 62 | -7 | 12 | 7 |
Ingresos de calidad: HQY tiene ganancias de alta calidad.
Margen de beneficios creciente: HQY pasó a ser rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de HQY han disminuido en un 43.2% al año en los últimos 5 años.
Acelerando crecimiento: HQY ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.
Beneficios vs. Industria: HQY ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare (7.3%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de HQY (2.7%) se considera baja.